WGC
PFE icon

Watts Gwilliam & Co’s Pfizer PFE Stock Holding History

Watts Gwilliam & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.02M Hold
79,423
– – 0.33% 57
2025
Q2 		$1.92M Buy
79,423
+50,744
+177% +$1.18M 0.31% 60
2025
Q1 		$727K Sell
28,679
-1,289
-4% -$33.7K 0.16% 103
2024
Q4 		$813K Sell
29,968
-63
-0.2% -$1.71K 0.17% 98
2024
Q3 		$876K Buy
+30,031
New +$876K 0.19% 93
2024
Q1 		$781K Buy
+27,533
New +$764K 0.24% 79

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Watts Gwilliam & Co's PFE Position: Q3 2025 in Review

Watts Gwilliam & Co held its Pfizer (PFE) position steady in Q3 2025 at 79,423 shares worth $2.02M. The position accounts for 0.33% of the portfolio, ranked #57.

Watts Gwilliam & Co first reported a position in PFE in Q1 2024 and has held it in 6 quarters since. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Watts Gwilliam & Co held 79,423 shares of Pfizer worth $2.02M as of Q3 2025.
  • Watts Gwilliam & Co left its Pfizer share count unchanged in Q3 2025.
  • Pfizer made up 0.33% of Watts Gwilliam & Co's portfolio in Q3 2025, its #57 holding.
  • Watts Gwilliam & Co first reported a position in Pfizer in Q1 2024 and has held it in 6 quarters since.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Watts Gwilliam & Co's 13F filing for Q3 2025, filed 21 Nov 2025.